Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)
Status:
Completed
Trial end date:
2017-03-07
Target enrollment:
Participant gender:
Summary
This is a study to assess the safety and efficacy of the addition of ipragliflozin to
sitagliptin in Japanese participants with Type 2 diabetes mellitus (T2DM) who have inadequate
glycemic control on sitagliptin, diet, and exercise therapy.